Fei Su

机构：Bengbu Medical College, Shanxi Medical University, Changzhi Medical College, The Second Affiliated Hospital of Bengbu Medical College, First Affiliated Hospital of Bengbu Medical College · ORCID：0000-0003-4737-4651

发表论文 143 篇 · 总被引 6974 次 · h-index 22

代表论文

• Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer (2024 · Biomarker Research · 被引 33)
• TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress (2024 · Molecular Biology Reports · 被引 29)
• Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials (2024 · Annals of Oncology · 被引 14)
• A systematic review of gastritis as an immune-related adverse event in clinical interventions (2024 · Human Vaccines & Immunotherapeutics · 被引 8)
• Effects of Butylphthalide Combined with Fasudil on Inflammatory Factors, Cognitive Function and Vascular Endothelial Function in Patients with Subarachnoid Hemorrhage Complicated with Cerebral Vasospasm (2023 · Pakistan Journal of Medical Sciences · 被引 6)
• Study on the synthesis of iron-based nanomedicine assisted by angelica sinensis polysaccharide with enhanced retention performance and its application in anemia treatment (2024 · International Journal of Biological Macromolecules · 被引 5)